Results 1 to 10 of about 53,092 (237)

Fructose and Non-Alcoholic Steatohepatitis [PDF]

Frontiers in Pharmacology, 2021
Background: The excessive consumption of free sugars is mainly responsible for the high prevalence of obesity and metabolic syndrome in industrialized countries.
Elke Roeb, Ralf Weiskirchen
doaj   +4 more sources

Statins in Non-alcoholic Steatohepatitis [PDF]

Frontiers in Cardiovascular Medicine, 2021
Non-alcoholic fatty liver disease (NAFLD) is the primary cause of chronic liver disease. The range is extensive, including hepatocellular carcinoma, cirrhosis, fibrosis, fatty liver, and non-alcoholic steatohepatitis (NASH).
Jose D. Torres-Peña, Jose D. Torres-Peña, Laura Martín-Piedra, Laura Martín-Piedra, Francisco Fuentes-Jiménez, Francisco Fuentes-Jiménez   +5 more
doaj   +5 more sources

Western diet contributes to the pathogenesis of non-alcoholic steatohepatitis in male mice via remodeling gut microbiota and increasing production of 2-oleoylglycerol

Nature Communications, 2023
The interplay between western diet and gut microbiota drives the development of non-alcoholic fatty liver disease and its progression to non-alcoholic steatohepatitis.
Ming Yang, Xiaoqiang Qi, Nan Li, Jussuf T. Kaifi, Shiyou Chen, Andrew A. Wheeler, Eric T. Kimchi, Aaron C. Ericsson, R. Scott Rector, Kevin F. Staveley-O’Carroll, Guangfu Li   +10 more
doaj   +2 more sources

Non-alcoholic Steatohepatitis: An Overview

Journal of the Formosan Medical Association, 2009
Non-alcoholic fatty liver disease (NAFLD) includes a broad spectrum of fat-induced liver injury, ranging from mild steatosis to cirrhosis and liver failure.
Allison Shifflet, George Y. Wu
doaj   +3 more sources

Endocannabinoids and non-alcoholic steatohepatitis

The Saudi Journal of Gastroenterology, 2006
Non alcoholic steatohepatitis (NASH) has gained a lot of attention recently due to the increased prevalence of diabetes, obesity, and hyperlipedemia. The endogenous compounds, endocannabinoids (ECBs), bind to the same receptors as tetrahydrocannabinol ...
Helmy Ahmed
doaj   +3 more sources

Machine learning model for non-alcoholic steatohepatitis diagnosis based on ultrasound radiomics [PDF]

BMC Medical Imaging
Background Non-Alcoholic Steatohepatitis (NASH) is a crucial stage in the progression of Non-Alcoholic Fatty Liver Disease(NAFLD). The purpose of this study is to explore the clinical value of ultrasound features and radiological analysis in predicting ...
Fei Xia, Wei Wei, Junli Wang, Yayang Duan, Kun Wang, Chaoxue Zhang   +5 more
doaj   +2 more sources

Recurrent and de novo non-alcoholic steatohepatitis following orthotopic liver transplantation [PDF]

Arquivos de Gastroenterologia, 2001
Background — Non-alcoholic steatohepatitis was coined in 1980 to describe pathological and clinical features of non-alcoholic disease associated with pathological features, commonly seen in alcoholic-liver disease itself.
Raquel F. Liermann GARCIA, Eugenia MORALES, Christian Evangelista GARCIA, Sushma SAKSENA, Stefan G. HÜBSCHER, Elwin ELIAS   +5 more
doaj   +1 more source

Alcoholic and non-alcoholic steatohepatitis [PDF]

Experimental and Molecular Pathology, 2014
This paper is based upon the “Charles Lieber Satellite Symposia” organized by Manuela G. Neuman at the Research Society on Alcoholism (RSA) Annual Meetings, 2013 and 2014. The present review includes pre-clinical, translational and clinical research that characterize alcoholic liver disease (ALD) and non-alcoholic steatohepatitis (NASH). In addition, a
Manuela G, Neuman, Samuel W, French, Barbara A, French, Helmut K, Seitz, Lawrence B, Cohen, Sebastian, Mueller, Natalia A, Osna, Kusum K, Kharbanda, Devanshi, Seth, Abraham, Bautista, Kyle J, Thompson, Iain H, McKillop, Irina A, Kirpich, Craig J, McClain, Ramon, Bataller, Radu M, Nanau, Mihai, Voiculescu, Mihai, Opris, Hong, Shen, Brittany, Tillman, Jun, Li, Hui, Liu, Paul G, Thomes, Murali, Ganesan, Steve, Malnick   +24 more
openaire   +2 more sources

Metabolomic Predictors of Non-alcoholic Steatohepatitis and Advanced Fibrosis in Children

Frontiers in Microbiology, 2021
Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in western countries both in children and adults. Metabolic dysregulation associated with gut microbial dysbiosis may influence disease progression from hepatic ...
Kattayoun Kordy, Kattayoun Kordy, Fan Li, David J. Lee, Jason M. Kinchen, Michael H. Jew, Maria Eduarda La Rocque, Sara Zabih, Monica Saavedra, Cora Woodward, Nicole J. Cunningham, Nicole H. Tobin, Grace M. Aldrovandi   +12 more
doaj   +1 more source

Treatment of non-alcoholic steatohepatitis [PDF]

Best Practice & Research Clinical Gastroenterology, 2002
Treatment of patients with non-alcoholic steatohepatitis (NASH) has typically been focused on the management of associated conditions such as obesity, diabetes mellitus and hyperlipidaemia. NASH associated with obesity may resolve with weight reduction, although the benefits of weight loss have been inconsistent.
Paul, Angulo, Keith D, Lindor
openaire   +2 more sources